Compare Kertas Basuki Rachmat Indonesia Tbk. (KBRI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kertas Basuki Rachmat Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Kertas Basuki Rachmat Indonesia Tbk. trades at Rp50 (market cap 434.4B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Kertas Basuki Rachmat Indonesia Tbk. is far larger — about 4.2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| KBRI | SCPI | |
|---|---|---|
Market Cap | 434.4B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kertas Basuki Rachmat Indonesia Tbk.
PT Kertas Basuki Rachmat Indonesia (the company) was established under its original name of PT Petroneks base on notarial deed No.21 of Mrs E Sianipar, S.H, dated on Apr 4, 1979. The Company’s articles of association has been amended several times, most recently by notarial deed No. 22 of Sutjipto, S.H., dated Feb 5, 2008, concerning among others, the change in the Company’s name.
Read more on KBRI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
